Amide-type adduct of dopamine - plausible cause of Parkinson diseases.

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Sub-cellular biochemistry

• Publication date

  Unknown publication date

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1007/978-94-007-7920-4_4PMID 24374917
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Dopamine- or L-DOPA-induced neurotoxicity: The role of dopamine quinone formation and tyrosinase in a model of Parkinson’s disease

  2009cited by this paper
• DHA Hydroperoxides as a Potential Inducer of Neuronal Cell Death: a Mitochondrial Dysfunction-Mediated Pathway

  2008cited by this paper
• Oxidative Modification of Peroxiredoxin Is Associated with Drug-induced Apoptotic Signaling in Experimental Models of Parkinson Disease*

  2008cited by this paper
• Trans‐4‐hydroxy‐2‐hexenal is a neurotoxic product of docosahexaenoic (22:6; n‐3) acid oxidation

  2008cited by this paper
• Brain mitochondrial dysfunction in aging

  2008cited by this paper
• Potent induction of total cellular GSH and NQO1 as well as mitochondrial GSH by 3H-1,2-dithiole-3-thione in SH-SY5Y neuroblastoma cells and primary human neurons: protection against neurocytotoxicity elicited by dopamine, 6-hydroxydopamine, 4-hydroxy-2-nonenal, or hydrogen peroxide.

  2008cited by this paper
• Pathophysiology of parkinsonism.

  2008cited by this paper
• Prenatal long-chain polyunsaturated fatty acid status: the importance of a balanced intake of docosahexaenoic acid and arachidonic acid

  2008cited by this paper
• The mitochondrial energy transduction system and the aging process.

  2007cited by this paper
• The oxidative stress metabolite 4-hydroxynonenal promotes Alzheimer protofibril formation.

  2007cited by this paper
• Omega-3 Fatty Acid Docosahexaenoic Acid Increases SorLA/LR11, a Sorting Protein with Reduced Expression in Sporadic Alzheimer's Disease (AD): Relevance to AD Prevention

  2007cited by this paper
• Transcriptional control of midbrain dopaminergic neuron development

  2006cited by this paper
• Formation of Nepsilon-(succinyl)lysine in vivo: a novel marker for docosahexaenoic acid-derived protein modification.

  2006cited by this paper
• Calcium, mitochondria and oxidative stress in neuronal pathology

  2006cited by this paper
• 6-Hydroxydopamine-induced Apoptosis Is Mediated via Extracellular Auto-oxidation and Caspase 3-dependent Activation of Protein Kinase Cδ*

  2006cited by this paper
• Novel aspects of an enduring theme

  2006cited by this paper
• Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases

  2006cited by this paper
• Neurotransmitter transporters: molecular function of important drug targets.

  2006cited by this paper
• Functional Repression of cAMP Response Element in 6-Hydroxydopamine-treated Neuronal Cells*

  2006cited by this paper
• Identification of a Lipid Peroxidation Product as a Potential Trigger of the p53 Pathway*

  2006cited by this paper
• sn-Position determination of phospholipid-linked fatty acids derived from erythrocytes by liquid chromatography electrospray ionization ion-trap mass spectrometry

  2005cited by this paper
• Tests in Tokyo reveal flaws in Vietnam's bird flu surveillance

  2005cited by this paper
• Toxin-induced models of Parkinson’s disease

  2005cited by this paper
• l-DOPA administration enhances 6-hydroxydopamine generation.

  2005cited by this paper
• Oxidative stress and inflammation in Parkinson's disease: is there a causal link?

  2005cited by this paper
• p‐quinone mediates 6‐hydroxydopamine‐induced dopaminergic neuronal death and ferrous iron accelerates the conversion of p‐quinone into melanin extracellularly

  2005cited by this paper
• Mitochondria, oxidants, and aging.

  2005cited by this paper
• Oxidative stress in brain aging, neurodegenerative and vascular diseases: an overview.

  2005cited by this paper
• Iron, brain ageing and neurodegenerative disorders

  2004cited by this paper
• Isoprostanes and related products of lipid peroxidation in neurodegenerative diseases.

  2004cited by this paper
• Plasma and CSF markers of oxidative stress are increased in Parkinson's disease and influenced by antiparkinsonian medication.

  2004cited by this paper
• Rat brain arachidonic acid metabolism is increased by a 6‐day intracerebral ventricular infusion of bacterial lipopolysaccharide

  2004cited by this paper
• Esterified lipid hydroperoxide-derived modification of protein: formation of a carboxyalkylamide-type lysine adduct in human atherosclerotic lesions.

  2004cited by this paper
• An inhibitor of mitochondrial complex I, rotenone, inactivates proteasome by oxidative modification and induces aggregation of oxidized proteins in SH‐SY5Y cells

  2003cited by this paper
• Immunochemical detection of a novel lysine adduct using an antibody to linoleic acid hydroperoxide-modified protein Published, JLR Papers in Press, April 16, 2003. DOI 10.1194/jlr.M200442-JLR200

  2003cited by this paper
• The structure of neuromelanin as studied by chemical degradative methods

  2003cited by this paper
• Oxidative stress in Parkinson's disease

  2003cited by this paper
• Current research on methamphetamine-induced neurotoxicity: animal models of monoamine disruption.

  2003cited by this paper
• Imaging of brain serotonergic neurotransmission involving phospholipase A2 activation and arachidonic acid release in unanesthetized rats.

  2003cited by this paper
• A role for tumor necrosis factor alpha in death of dopaminergic neurons following neural transplantation.

  2002cited by this paper
• Polyunsaturated fatty acids (PUFA) and eicosanoids in human health and pathologies.

  2002cited by this paper
• Oxidation of dopamine to aminochrome as a mechanism for neurodegeneration of dopaminergic systems in Parkinson's disease. Possible neuroprotective role of DT-diaphorase.

  2002cited by this paper
• Cell death in Parkinson's disease

  2002cited by this paper
• Hypoxia signaling to genes

  2002cited by this paper
• Causes of neuronal death in Parkinson's disease.

  2001cited by this paper
• Role of Mitochondria in Neuronal Apoptosis

  2000cited by this paper
• Dopamine Oxidation Alters Mitochondrial Respiration and Induces Permeability Transition in Brain Mitochondria

  1999cited by this paper
• Essential fatty acids in health and chronic disease.

  1999cited by this paper
• Formation of Nepsilon-(hexanonyl)lysine in protein exposed to lipid hydroperoxide. A plausible marker for lipid hydroperoxide-derived protein modification.

  1999cited by this paper
• Peroxynitrite‐ and Nitrite‐Induced Oxidation of Dopamine : Implications for Nitric Oxide in Dopaminergic Cell Loss

  1999cited by this paper
• In Vivo Fatty Acid Incorporation into Brain Phospholipids in Relation to Signal Transduction and Membrane Remodeling

  1999cited by this paper
• The ubiquitin pathway in Parkinson's disease

  1998cited by this paper
• Detection of oxidized phospholipid-protein adducts using anti-15-hydroperoxyeicosatetraenoic acid-modified protein antibody: contribution of esterified fatty acid-protein adduct to oxidative modification of LDL.

  1998cited by this paper
• Iron-mediated generation of the neurotoxin 6-hydroxydopamine quinone by reaction of fatty acid hydroperoxides with dopamine: a possible contributory mechanism for neuronal degeneration in Parkinson's disease.

  1997cited by this paper
• Characterization of a specific polyclonal antibody against 13-hydroperoxyoctadecadienoic acid-modified protein: formation of lipid hydroperoxide-modified apoB-100 in oxidized LDL.

  1997cited by this paper
• The Release of Cytochrome c from Mitochondria: A Primary Site for Bcl-2 Regulation of Apoptosis

  1997cited by this paper
• Immunohistochemical detection of 4-hydroxynonenal protein adducts in Parkinson disease.

  1996cited by this paper
• Age-related losses of cognitive function and motor skills in mice are associated with oxidative protein damage in the brain.

  1996cited by this paper
• Mechanisms of free radical oxidation of unsaturated lipids

  1995cited by this paper
• Oxidative stress: free radical production in neural degeneration.

  1994cited by this paper
• Fatty acid and phospholipid selectivity of different phospholipase A2 enzymes studied by using a mammalian membrane as substrate.

  1994cited by this paper
• Oxidative stress: Free radical production in neural degeneration

  1994cited by this paper
• Increased levels of lipid hydroperoxides in the parkinsonian substantia nigra: An HPLC and ESR study

  1994cited by this paper
• The oxidant stress hypothesis in Parkinson's disease: Evidence supporting it

  1992cited by this paper
• Basal Lipid Peroxidation in Substantia Nigra Is Increased in Parkinson's Disease

  1989cited by this paper
• Model experiments on the molecular mechanism of action of 6-hydroxydopamine.

  1971cited by this paper

• Experimental models of chemically induced Parkinson’s disease in zebrafish at the embryonic larval stage: a systematic review

  2023cites this paper
• Polydopamine-loaded prunetin nanomaterials activate DRD2 to reduce UV-induced inflammation by stabilizing and promoting Nrf2 nuclear translocation.

  2023cites this paper
• N-3 (Omega-3) Fatty Acids: Effects on Brain Dopamine Systems and Potential Role in the Etiology and Treatment of Neuropsychiatric Disorders.

  2018cites this paper
• Autoxidation of Plasma Lipids, Generation of Bioactive Products, and Their Biological Relevance

  2015cites this paper